MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A.
Li H, Li X, Ge X, Jia L, Zhang Z, Fang R, Yang J, Liu J, Peng S, Zhou M, Xiang J, Zeng Z, Zhou W, Xiong W, Xiao G, Fang L, Li GY, Li Z.
Li H, et al. Among authors: fang l, fang r.
Oncotarget. 2016 Aug 23;7(34):54838-54851. doi: 10.18632/oncotarget.10761.
Oncotarget. 2016.
PMID: 27458165
Free PMC article.